PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of itxAboutfor AuthorsVersitaInterdisciplinary Toxicology
 
Interdiscip Toxicol. 2009 March; 2(1): 24–27.
Published online 2009 March. doi:  10.2478/v10102-009-0004-4
PMCID: PMC2984092

Genotoxic mechanisms for the carcinogenicity of the environmental pollutants and carcinogens o-anisidine and 2-nitroanisole follow from adducts generated by their metabolite N-(2-methoxyphenyl)-hydroxylamine with deoxyguanosine in DNA

Abstract

An aromatic amine, o-anisidine (2-methoxyaniline) and its oxidative counterpart, 2-nitroanisole (2-methoxynitrobenzene), are the industrial and environmental pollutants causing tumors of the urinary bladder in rats and mice. Both carcinogens are activated to the same proximate carcinogenic metabolite, N-(2-methoxyphenyl)hydroxylamine, which spontaneously decomposes to nitrenium and/or carbenium ions responsible for formation of deoxyguanosine adducts in DNA in vitro and in vivo. In other words, generation of N-(2-methoxyphenyl)hydroxylamine is responsible for the genotoxic mechanisms of the o-anisidine and 2-nitroanisole carcinogenicity. Analogous enzymes of human and rat livers are capable of activating these carcinogens. Namely, human and rat cytochorme P4502E1 is the major enzyme oxidizing o-anisidine to N-(2-methoxyphenyl)hydroxylamine, while xanthine oxidase of both species reduces 2-nitroanisole to this metabolite. Likewise, O-demethylation of 2-nitroanisole, which is the detoxication pathway of its metabolism, is also catalyzed by the same human and rat enzyme, cytochorme P450 2E1. The results demonstrate that the rat is a suitable animal model mimicking the fate of both carcinogens in humans and suggest that both compounds are potential carcinogens also for humans.

Keywords: carcinogens, o-anisidine, 2-nitroanisole, N-(2-methoxyphenyl)hydroxylamine, metabolism, DNA adducts, cancer

Introduction

Aromatic nitro-compounds and amines are potent toxic or carcinogenic compounds, presenting a considerable danger to the human population (NTP, 1978; 1993; Garner et al., 1984; IARC, 1982;1989). They are widely distributed environmental pollutants found in workplaces (e.g. in chemical industry), in emissions from diesel and gasoline engines and on the surface of ambient air particulate matter (IARC, 1989; 1982; NTP, 1978; 1993), where they add to local and regional pollution (car exhausts, technological spills). The toxicity and carcinogenicity of these compounds, their metabolic pathways and the persistence of residues of these compounds and/or their metabolites in organisms have been examined (NTP, 1978; 1993; IARC, 1989; 1982; Purohit and Basu, 2000). However, the knowledge of the fate of several aromatic nitro compounds or aromatic amines and their physiological effects in humans is still scarce (Purohit and Basu, 2000). This also the case of compounds such as 2-methoxyaniline (o-anisidine) and 2-nitroanisole (2-methoxynitrobenzene) (Figures 1 and and22).

Figure 1
Pathways of o-anisidine metabolism by the cytochrome P450 system showing the characterized metabolites and those proposed to form DNA adducts. The compounds shown in brackets were not detected under the experimental conditions.
Figure 2
Pathways of 2-nitroanisole metabolism showing the characterized metabolites and those proposed to form DNA adducts. The compounds shown in brackets were not detected under the experimental conditions.

Toxicity, carcinogenicity and metabolism of o-anisidine and 2-nitroanisole

o-Anisidine and 2-nitroanisole are potent carcinogens, causing tumors of the urinary bladder in both genders of rats and mice (NTP, 1978; IARC, 1982; NTP, 1993). The International Agency for Research on Cancer (IARC) has classified o-anisidine as a group 2B carcinogens (IARC, 1982), which is possibly carcinogenic to humans. Besides its carcinogenicity it exhibits other toxic effects, including hematological changes, anemia and nephrotoxicity (NTP, 1978; IARC, 1982). o-Anisidine is used as an intermediate in the manufacturing of a number of azo and naphthol pigments and dyes, which are used for printing (90%) and for paper (3%) and textile (7%) dyeing (NTP, 1978; Garner et al., 1984). Such a wide use of this aromatic amine could result in occupational exposure. Furthermore, it may be released from textiles and leather goods colored with these azo dyes and a large part of the population may be exposed. This carcinogen is also a constituent of cigarette smoke (IARC, 1982; Stabbert et al., 2003). This strongly suggests that o-anisidine ranks not only among occupational pollutants produced in the manufacturing of chemicals, but also among environmental pollutants; it can be assumed that human exposure is widespread. Indeed, o-anisidine was found in human urine samples in the general population, in concentrations of 0.22 µg/l (median) (Weiss and Angerer, 2003). In addition, hemoglobin adducts of o-anisidine were detected in blood samples of persons living in urban or rural areas of Germany (Falter et al., 1994; Branner et al., 1998; Richter et al., 2001). The adducts as well as o-anisidine in urine might originate not only from the sources mentioned above, but also from a possible o-anisidine precursor, 2-methoxynitrobenzene (2-nitroanisole). This chemical was released into the environment in the course of an accident in a German chemical plant, causing subsequently local and regional contamination (Falter et al., 1994; Hauthal, 1993; Traupe et al., 1997). 2-Nitroanisole exhibits strong carcinogenic activity, causing neoplastic transformation in the urinary bladder, and to a lesser extent, in the spleen, liver and kidneys in rodents (NTP 1993). It is also a toxic compound, causing anemia. The anemia is characterized by increased levels of methemoglobin and accelerated destruction of erythrocytes (NTP 1993).

Recently, we have found that o-anisidine is oxidatively activated by peroxidase and cytochrome P450 (CYP) to species binding to DNA in vitro (Stiborová et al., 2001, 2002; 2005; Rýdlová et al., 2005; Naiman et al., 2008b). We also demonstrated that o-anisidine forms DNA adducts in vivo. The same adducts as found in DNA incubated with o-anisidine and human microsomes in vitro were detected in urinary bladder, the target organ, and to a lesser extent, in liver, kidney and spleen of rats treated with o-anisidine (Stiborová et al., 2005). The o-anisidine-derived DNA adducts were identified as deoxyguanosine adducts formed from a metabolite of o-anisidine, N-(2-methoxyphenyl)hydroxylamine, which is generated by oxidation of o-anisidine with human, rabbit and rat hepatic microsomes (Stiborová et al., 2005; Rýdlová et al., 2005; Naiman et al., 2008b). The same deoxyguanosine adducts were also detected in DNA of the urinary bladder, kidney, liver and spleen of rats treated with 2-nitroanisole (Stiborová et al., 2004), an oxidized counterpart of o-anisidine, and in DNA incubated with 2-nitroanisole in vitro with human and rat hepatic cytosolic enzymes and xanthine oxidase (Stiborová et al., 1998; 2004). These enzymatic systems were found to produce N-(2-methoxyphenyl)hydroxylamine after 2-nitroanisole reduction (Mikšanová et al., 2004a) (Figure 2). The data indicate that formation of N-(2-methoxyphenyl)hydroxylamine, the reactive metabolite of both carcinogens, is critical for generation of DNA lesions in target organs. Therefore, it is clear that N-(2-methoxyphenyl)hydroxylamine formation and its further conversion, as well as the enzymes participating in such processes, play a key role in carcinogenic effects of both carcinogens. Oxidation of 2-nitroanisole by rat, rabbit and human hepatic microsomal cytochrome P450 enzymes leads to its detoxication. O-Demethylation of 2-nitroanisole to 2-nitrophenol and its hydroxylated products, 2,5-dihydroxynitrobenzene and 2,6-dihydroxynitrobenzene, did not form any adducts with DNA (Mikšanová et al., 2004b; Dračínská et al., 2006). 2-Nitroanisole metabolite 2-nitrophenol is the major metabolite generated by rabbit and rat microsomal enzymes, but 2,5-dihydroxynitrobenzene is the predominant product formed in human microsomal cytochromes P450 (Mikšanová et al., 2004b; Dračínská et al., 2006; Svobodová et al., 2008) (Figure 2). Therefore, hepatic microsomal P450 enzymes participate in detoxication of this environmental carcinogen.

Recently, we have found that o-anisidine is oxidized by human, rat and rabbit hepatic microsomes containing cytochromes P450 not only to N-(2-methoxyphenyl)hydroxylamine, but that this compound is a subject of complex redox cycling reactions, forming also o-aminophenol, 2-nitrosoanisole and one additional metabolite, the exact structure of which has not been identified as yet (Stiborová et al., 2005; Naiman et al., 2008a; 2008b). N-(2-methoxyphenyl)hydroxylamine might also be a subject of complex reactions, and its fate is dependent on the environment, in which it occurs. It can be further metabolized to o-aminophenol, o-nitrosoanisole and parental o-anisidine (Naiman et al., 2008a; 2008b), or when nucleophiles such as DNA or proteins are present in the cell, form the adducts (Stiborová et al., 2005) (Figure 1).

Conclusion

The results of our former (Stiborová et al., 1998; 2004; 2005) and the present studies (unpublished data) indicate that three DNA adducts found in vitro and in vivo are formed from N-(2-methoxyphenyl)hydroxylamine and deoxyguanosine in DNA. The physico-chemical properties of these adducts suggest that they are polar compounds, in which only one benzene ring of the original o-anisidine and/or 2-nitroanisole molecules is bound to this deoxynucleoside. Recently, their structures were suggested to be the structures of adducts, in which nitrenium and/or carbenium ions formed from N-(2-methoxyphenyl)hydroxylamine are bound to C8, O6, and/or N2 in the guanine residue (Stiborová et al., 2005). The aim of our current and future research in our laboratory is to confirm this suggestion. Procedures to prepare the adducts generated by reactions N-(2-methoxyphenyl)hydroxylamine with deoxygunaosine and HPLC methods to separate adducts from other components of the reaction mixtures were developed in our laboratory. They will lead to obtain adducts in amounts sufficient for their structural characterization by mass- and NMR spectrometry.

Acknowledgement

The work is supported by Grant Agency of Charles University (grant 7418/2007), the Grant Agency of the Czech Republic (grants 303/09/0472 and 203/09/0812) and the Ministry of Education of the Czech Republic (grants MSM0021620808 and 1M0505).

REFERENCES

  • Branner B, Kutzer C, Zwickenpflug W, Scherer G, Heller W-D, Richter E. Haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and non-smoking women. Biomarkers. 1998;3:35–47. [PubMed]
  • Dračínská H, Mikšanová M, Svobodová M, Smrček S, Frei E, Schmeiser HH, Stiborová M. Oxidative detoxication of carcinogenic 2-nitroanisole by human, rat and rabbit cytochrome P450. Neuro Endocrinol. Lett. 2006;27:9–13. [PubMed]
  • Falter B, Kutzer C, Richter E. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin Investig. 1994;72:364–371. [PubMed]
  • Garner RC, Martin CN, Clayson DB. Carcinogenic aromatic amines and related compounds. In: Searle C, editor. Chemical Carcinogens, ACS Monograph 182. 2nd ed. Vol. 1. Washington, DC: American Chemical Society; 1984. pp. 175–302.
  • Hauthal HG. Rosenmontag und die Folgen die Störfälle der Hoechst AG. Nach Chem Tech Lab. 1993;41:440.
  • IARC. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon: IARC; 1982. Ortho- and para-anisidine and their hydrochlorides. No. 27. [PubMed]
  • IARC. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 88. Lyon: IARC; 2006. Formaldehyde, 2-butoxyethanol and 1-terc-butoxypropan-2-ol; pp. 39–325. [PubMed]
  • Mikšanová M, Novák P, Frei E, Stiborová M. Metabolism of carcinogenic 2-nitroanisole by rat, rabbit, porcine and human hepatic cytosol. Collect Czech Chem Commun. 2004a;69:589–602.
  • Mikšanová M, Sulc M, Rýdlová H, Schmeiser HH, Frei E, Stiborová M. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450. Chem. Res. Toxicol. 2004b;17:663–671. [PubMed]
  • Naiman K, Dračínská H, Dračínský M, Martínková M, Martínek V, Hodek P, Štícha M, Frei E, Stiborová M. Cytochrome P450-mediated metabolism of N-(2-methoxyphenyl)-hydroxylamine, a human metabolite of the environmental pollutants and carcinogens o-anisidine and o-nitroanisole Interdisc. Toxicol. 2008a;1:218–224. [PMC free article] [PubMed]
  • Naiman K, Dračínská H, Martínková M, Šulc M, Dračínský M, Kejíková L, Hodek P, Hudeček J, Liberda J, Schmeiser HH, Frei E, Stiborová M. Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes. Chem Res Toxicol. 2008b;21:1610–1621. [PubMed]
  • NTP. NTP Technical Report 89. Bethesda, MD: National Institute of Health, US Department of Health and Human Services; 1978. Bioassay of o-anisidine hydrochloride for possible carcinogenicity.
  • NTP. NTP Technical Report 416. Bethesda, MD: National Institute of Health, US Department of Health and Human Services; 1993. Toxicology and Carcinogenesis. Studies of 2-nitroanisole.
  • Purohit V, Basu A. Mutagenicity of nitroaromatic compounds. Chem Res Toxicol. 2000;13:673–692. [PubMed]
  • Richter E, Rosler S, Scherer G, Gostomzyk JG, Grubl A, Kamer U, Behrendt H. Haemoglobin adducts from aromatic amines in children in relation to area of residence and exposure to environmental tobacco smoke. Int Arch Occup Environ Health. 2001;74:421–428. [PubMed]
  • Rýdlová H, Mikšanová M, Ryšlavá H, Stiborová M. Carcinogenic pollutants o-nitroanisole and o-anisidine are substrates and inducers of cytochromes P450. Biomed Papers. 2005;49:441–447. [PubMed]
  • Stabbert R, Schäfer K-H, Biefel C, Rustemeier K. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom. 2003;17:2125–2132. [PubMed]
  • Stiborová M, Mikšanová M, Havlíček V, Schmeiser HH, Frei E. Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat Res. 2002;500:49–66. [PubMed]
  • Stiborová M, Mikšanová M, Smrček S, Bieler CA, Breuer A, Klokow KA, Schmeiser HH, Frei E. Identification of a genotoxic mechanism for 2-nitroanisole carcinogenicity and of its carcinogenic potential for humans. Carcinogenesis. 2004;25:833–840. [PubMed]
  • Stiborová M, Mikšanová M, Šulc M, Rýdlová H, Schmeiser HH, Frei E. Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine. Int J Cancer. 2005;116:667–678. [PubMed]
  • Stiborová M, Schmeiser HH, Breuer A, Frei E. Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adducts formation. Gen Physiol Biophys. 2001;20:267–279. [PubMed]
  • Stiborová M, Schmeiser HH, Frei E. To the mechanism of 2-nitroanisole carcinogenicity: in vitro metabolism of 2-nitroanisole mediated by peroxidases and xanthine oxidase. Collect Czech Chem Commun. 1998;63:857–869.
  • Svobodová M, Dračínská H, Martínková M, Hudeček J, Hodek P, Frei E, Stiborová M. Oxidation of carcinogenic 2-nitroanisole by rat cytochrome P450 – similarity between human and rat systems. Interdisc Toxicol. 2008;1:180–185. [PMC free article] [PubMed]
  • Traupe H, Menge G, Kandt J, Karmaus W. Higher frequency of atopic dermatitis and decrease in viral warts among children exposed to chemicals liberated in a chemical accident in Frankfurt, Germany. Dermatology. 1997;195:112–118. [PubMed]
  • U.S. Department of Health and Human Services. 11th Report on Carcinogens. Washington, DC: U.S. Government Printing Office; 2004.
  • Weiss T, Angerer J. Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J Chromatogr B. 2003;778:179–192. [PubMed]

Articles from Interdisciplinary Toxicology are provided here courtesy of Slovak Toxicology Society SETOX & Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences